←Back to Expert Scholars
Translational Medicine / 转化医学Theranostics, PSMA and DOTATATE
Oliver Sartor
MD
🏢Mayo Clinic🌐USA
Director of Radiopharmaceutical Trials
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Oliver Sartor is a medical oncologist who led the pivotal ALSYMPCA trial of radium-223 and has been central to the development of PSMA radioligand therapy including VISION. He is a leading voice on the clinical implementation of radiopharmaceuticals. His work has defined modern prostate cancer radionuclide therapy.
Share:
🧪Research Fields 研究领域
radium-223
PSMA radioligand therapy
metastatic prostate cancer
clinical trials
alpha emitter therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Oliver Sartor 的研究动态
Follow Oliver Sartor's research updates
留下邮箱，当我们发布与 Oliver Sartor（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment